In March 2025, the company announced new programs to get a immediate-to-purchaser giving of its Wegovy weight loss drug. The company founded a whole new pharmacy, called NovoCare, which would cost clients $499 a month for access to the drug, below 50 percent the cost of the drug as a result of other pharmaceutical distribution networks.[fifty three